This study is a randomized (1:1:1) comparative effectiveness trial of medication (zolpidem or
trazodone), cognitive-behavioral therapy for insomnia (CBT-I), and the combination
(medication + CBT-I) for the treatment of chronic insomnia in men and women aged 18-80 living
in rural areas with 1 year of follow-up. A total of 1200 participants will be enrolled and
randomized in the United States. This trial is funded by the Patient-Centered Outcomes
Research Institute.
Phase:
Phase 4
Details
Lead Sponsor:
California Pacific Medical Center Research Institute
Collaborators:
Patient-Centered Outcomes Research Institute University of Arizona University of Illinois at Chicago University of Pittsburgh University of Virginia